PureTech Health plc (OTCMKTS:PTCHF – Get Free Report)’s stock price was down 2% during trading on Tuesday. The stock traded as low as $1.4450 and last traded at $1.51. Approximately 11,775 shares traded hands during mid-day trading, a decline of 65% from the average daily volume of 34,122 shares. The stock had previously closed at $1.5410.
PureTech Health Trading Down 2.0%
The firm has a 50-day simple moving average of $1.57 and a 200 day simple moving average of $1.64.
PureTech Health Company Profile
PureTech Health plc is a biopharmaceutical company that develops medicines for complex diseases, with a focus on therapeutic approaches designed to address significant unmet patient needs. The company combines its own research and development activities with a model of creating, financing and advancing subsidiary companies that pursue distinct therapeutic programs.
PureTech’s research platform includes orally administered medicines and other treatments intended to influence biological pathways that are difficult to target with conventional drug-delivery methods.
Recommended Stories
- Five stocks we like better than PureTech Health
- Constellation Energy’s Google Deal Shows Why Nuclear Uprates Matter for AI
- Lamb Weston’s Turnaround Is Starting to Look Real
- These 3 Stocks Got the Most Love From Analysts in September
- Record French Debt Could Create Opportunities for U.S. Market Operators
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
